Hidetoshi Mori

4.7k total citations · 2 hit papers
52 papers, 3.5k citations indexed

About

Hidetoshi Mori is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hidetoshi Mori has authored 52 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 22 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Hidetoshi Mori's work include Cancer Cells and Metastasis (14 papers), Protease and Inhibitor Mechanisms (12 papers) and Cell Adhesion Molecules Research (9 papers). Hidetoshi Mori is often cited by papers focused on Cancer Cells and Metastasis (14 papers), Protease and Inhibitor Mechanisms (12 papers) and Cell Adhesion Molecules Research (9 papers). Hidetoshi Mori collaborates with scholars based in United States, Japan and Spain. Hidetoshi Mori's co-authors include Mina J. Bissell, Motoharu Seiki, Yoshifumi Itoh, Masahiro Kajita, Hiroaki Kinoh, Akiko Okada, Cyrus M. Ghajar, Tadashige Chiba, Emily I. Chen and Dena Almeida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Hidetoshi Mori

52 papers receiving 3.5k citations

Hit Papers

The perivascular niche regulates breast tumo... 2001 2026 2009 2017 2013 2001 250 500 750

Peers

Hidetoshi Mori
R. Grant Rowe United States
Ute Reuning Germany
Nancy Boudreau United States
Kenn Holmbeck United States
Joni D. Mott United States
Lynn Neff United States
R. Grant Rowe United States
Hidetoshi Mori
Citations per year, relative to Hidetoshi Mori Hidetoshi Mori (= 1×) peers R. Grant Rowe

Countries citing papers authored by Hidetoshi Mori

Since Specialization
Citations

This map shows the geographic impact of Hidetoshi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Mori more than expected).

Fields of papers citing papers by Hidetoshi Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Mori. The network helps show where Hidetoshi Mori may publish in the future.

Co-authorship network of co-authors of Hidetoshi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Mori. A scholar is included among the top collaborators of Hidetoshi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Mori. Hidetoshi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, Claire, Emily Killingbeck, Alexander A. Merleev, et al.. (2024). Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors. Science Advances. 10(28). eadm8206–eadm8206. 7 indexed citations
2.
Esserman, Laura J., Alexa Glencer, Christopher J. Schwartz, et al.. (2024). Abstract PR07: Intratumoral injection of mRNA-2752 and anti-PD-1 results in rapid regression of HER2 positive and or Hormone Receptor Negative DCIS: Phase 1 study results. Cancer Research. 84(3_Supplement_1). PR07–PR07. 1 indexed citations
3.
Judge, Sean J., Morgan Darrow, Marshall Lammers, et al.. (2023). Intratumoral NKp46+ natural killer cells are spatially distanced from T and MHC-I+ cells with prognostic implications in soft tissue sarcoma. Frontiers in Immunology. 14. 1230534–1230534. 9 indexed citations
4.
Schwab, Julian, Qian Chen, Anna Luisa Kühn, et al.. (2022). Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysis. npj Breast Cancer. 8(1). 41–41. 2 indexed citations
5.
Díaz‐Valdivia, Natalia, Marta Gabasa, Evette S. Radisky, et al.. (2022). Aberrant TIMP-1 overexpression in tumor-associated fibroblasts drives tumor progression through CD63 in lung adenocarcinoma. Matrix Biology. 111. 207–225. 22 indexed citations
6.
Nachmanson, Daniela, Adam Officer, Hidetoshi Mori, et al.. (2022). The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ. npj Breast Cancer. 8(1). 6–6. 9 indexed citations
7.
Damaghi, Mehdi, Hidetoshi Mori, Liping Xu, et al.. (2020). Collagen production and niche engineering: A novel strategy for cancer cells to survive acidosis in DCIS and evolve. Evolutionary Applications. 13(10). 2689–2703. 15 indexed citations
8.
Mori, Hidetoshi, Pierre P. Massion, Clifford Hoyt, et al.. (2020). Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence. Journal of Mammary Gland Biology and Neoplasia. 25(4). 417–432. 27 indexed citations
9.
Sridharan, Deepa, et al.. (2020). Dose Fractionation During Puberty Is More Detrimental to Mammary Gland Development Than an Equivalent Acute Dose of Radiation Exposure. International Journal of Radiation Oncology*Biology*Physics. 109(5). 1521–1532. 1 indexed citations
10.
Spencer, Virginia A., et al.. (2017). Laminin-111 and the Level of Nuclear Actin Regulate Epithelial Quiescence via Exportin-6. Cell Reports. 19(10). 2102–2115. 58 indexed citations
11.
Mori, Hidetoshi & Robert D. Cardiff. (2016). Methods of Immunohistochemistry and Immunofluorescence: Converting Invisible to Visible. Methods in molecular biology. 1458. 1–12. 37 indexed citations
12.
Mori, Hidetoshi, Ramray Bhat, Alexandre Bruni‐Cardoso, et al.. (2016). New insight into the role of MMP14 in metabolic balance. PeerJ. 4. e2142–e2142. 19 indexed citations
13.
Mori, Hidetoshi, Robert D. Cardiff, Josephine F. Trott, et al.. (2015). Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent. PLoS ONE. 10(6). e0129895–e0129895. 7 indexed citations
14.
Radisky, Derek C., Yi Ling Eileen Koh, Jimmie E. Fata, et al.. (2013). Epimorphin Is a Novel Regulator of the Progesterone Receptor Isoform-A. Cancer Research. 73(18). 5719–5729. 5 indexed citations
15.
Ghajar, Cyrus M., Héctor Peinado, Hidetoshi Mori, et al.. (2013). The perivascular niche regulates breast tumour dormancy. Nature Cell Biology. 15(7). 807–817. 843 indexed citations breakdown →
16.
Andersen, Kristin, Hidetoshi Mori, Jimmie E. Fata, et al.. (2011). The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis. Developmental Biology. 352(2). 181–190. 23 indexed citations
17.
Suenaga, Naoko, Hidetoshi Mori, Yoshifumi Itoh, & Motoharu Seiki. (2004). CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene. 24(5). 859–868. 91 indexed citations
18.
Mori, Hidetoshi, Masaharu Kamada, Masahiko Maegawa, et al.. (1998). Enzymatic Activation of Immunoglobulin Binding Factor in Female Reproductive Tract. Biochemical and Biophysical Research Communications. 246(2). 409–413. 15 indexed citations
19.
Kamada, Masaharu, Hidetoshi Mori, Satoshi Yamamoto, et al.. (1998). β-Microseminoprotein/prostatic secretory protein is a member of immunoglobulin binding factor family. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1388(1). 101–110. 32 indexed citations
20.
Mori, Hidetoshi, Shuntaro Hara, Hiroshi Mizushima, et al.. (1991). Extracellular phospholipase A2 detected at inflamed sites in rats does not originate from platelets. Inflammation Research. 32(3-4). 266–269. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026